Viewing Study NCT02994927

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:11 AM
Ignite Modification Date: 2026-06-07 @ 2:03 AM
Study NCT ID: NCT02994927
Status: COMPLETED
Last Update Posted: 2025-03-24
First Post: 2016-12-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ANCA-Associated Vasculitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ANCA-associated vasculitis View
None complement View
None vasculitis View
None C5aR View
None avacopan View
None CCX168 View
None MPA View
None GPA View